S M Cadarette

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
    A M Burden
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, ON, Canada M5S 3M2
    Osteoporos Int 23:1075-82. 2012
  2. ncbi Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
    S M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, M5S 3M2, ON, Canada
    Osteoporos Int 23:1475-80. 2012
  3. ncbi Bisphosphonates and risk of atrial fibrillation: a meta-analysis
    Seo Young Kim
    Division of Rheumatology, Allergy and Immunology, Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, 02115, USA
    Arthritis Res Ther 12:R30. 2010
  4. ncbi Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing
    Suzanne M Cadarette
    Osteoporosis Research Program, Women s College Hospital, University of Toronto, Ontario, Canada
    Med Care 45:896-901. 2007
  5. ncbi Minimal error in self-report of having had DXA, but self-report of its results was poor
    Suzanne M Cadarette
    Osteoporosis Research Program, Women s College Hospital, Toronto, Ontario, Canada
    J Clin Epidemiol 60:1306-11. 2007
  6. ncbi Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Rheumatol 35:319-26. 2008
  7. ncbi Comparative gastrointestinal safety of weekly oral bisphosphonates
    S M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:1735-47. 2009
  8. ncbi Measuring patient perceptions about osteoporosis pharmacotherapy
    Suzanne M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
    BMC Res Notes 2:133. 2009
  9. ncbi Confounder summary scores when comparing the effects of multiple drug exposures
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 19:2-9. 2010
  10. ncbi Measuring and improving adherence to osteoporosis pharmacotherapy
    Suzanne M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Curr Opin Rheumatol 22:397-403. 2010

Detail Information

Publications33

  1. ncbi Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
    A M Burden
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, ON, Canada M5S 3M2
    Osteoporos Int 23:1075-82. 2012
    ..During a median observation period of 4.7 years, 10% of patients filled only a single prescription, 37% switched therapies and median cumulative exposure was 2.2 years...
  2. ncbi Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
    S M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, M5S 3M2, ON, Canada
    Osteoporos Int 23:1475-80. 2012
    ..Implications of differential access to oral bisphosphonates warrants further study...
  3. ncbi Bisphosphonates and risk of atrial fibrillation: a meta-analysis
    Seo Young Kim
    Division of Rheumatology, Allergy and Immunology, Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, 02115, USA
    Arthritis Res Ther 12:R30. 2010
    ....
  4. ncbi Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing
    Suzanne M Cadarette
    Osteoporosis Research Program, Women s College Hospital, University of Toronto, Ontario, Canada
    Med Care 45:896-901. 2007
    ....
  5. ncbi Minimal error in self-report of having had DXA, but self-report of its results was poor
    Suzanne M Cadarette
    Osteoporosis Research Program, Women s College Hospital, Toronto, Ontario, Canada
    J Clin Epidemiol 60:1306-11. 2007
    ..To examine the validity of both self-report of having had dual-energy x-ray absorptiometry (DXA) and self-reported DXA test results...
  6. ncbi Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Rheumatol 35:319-26. 2008
    ..To examine trends in osteoporosis drug prescribing after hip fracture from 1995 to 2004...
  7. ncbi Comparative gastrointestinal safety of weekly oral bisphosphonates
    S M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Osteoporos Int 20:1735-47. 2009
    ..We compared the gastrointestinal safety between weekly alendronate and weekly risedronate and found no important difference between new users of these agents...
  8. ncbi Measuring patient perceptions about osteoporosis pharmacotherapy
    Suzanne M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
    BMC Res Notes 2:133. 2009
    ..Further research is needed to develop scales that adequately measure perceived barriers to osteoporosis pharmacotherapy...
  9. ncbi Confounder summary scores when comparing the effects of multiple drug exposures
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 19:2-9. 2010
    ..We compared three analytic strategies to control for confounding based on measured variables: conventional multivariable, exposure propensity score (EPS), and disease risk score (DRS)...
  10. ncbi Measuring and improving adherence to osteoporosis pharmacotherapy
    Suzanne M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Curr Opin Rheumatol 22:397-403. 2010
    ..Although effective treatment exists, adherence to osteoporosis pharmacotherapy is suboptimal and linked to reduced drug effectiveness. In this paper, we review methods of measuring and improving adherence to osteoporosis pharmacotherapy...
  11. ncbi Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors
    S M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, ON, Canada M5S3M2
    Osteoporos Int 22:943-54. 2011
    ....
  12. ncbi Osteoporosis quality indicators using healthcare utilization data
    S M Cadarette
    Leslie Dan Faculty of Pharmacy, University of Toronto, Leslie L Dan Pharmacy Building, 144 College Street, Toronto, ON M5S 3M2, Canada
    Osteoporos Int 22:1335-42. 2011
    ..81) with minimal measurement error...
  13. ncbi Predictors of locating women six to eight years after contact: internet resources at recruitment may help to improve response rates in longitudinal research
    Suzanne M Cadarette
    Osteoporosis Research Program, Women s College Hospital, Toronto, Canada
    BMC Med Res Methodol 7:22. 2007
    ..The purpose of this study was to examine predictors of locating women requiring tracing using publicly available methods (primarily Internet searches), and to determine the additional benefit of vital statistics linkages...
  14. ncbi Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry
    S M Cadarette
    Canadian Multicentre Osteoporosis Study, University of Toronto, Ont
    CMAJ 162:1289-94. 2000
    ..The objective of this study was to develop and validate a clinical tool to help clinicians identify which women are at increased risk for osteoporosis and should therefore undergo further testing with bone densitometry...
  15. ncbi Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry
    S M Cadarette
    Osteoporosis Research Program, Women s College Ambulatory Care Centre, Sunnybrook and Women s College Health Sciences Centre, 76 Grenville St, 10th Floor E, Room 1005, Toronto, Ontario, Canada M5S 1B2
    JAMA 286:57-63. 2001
    ..Identification of women with low bone mineral density (BMD) is an important strategy in reducing the incidence of osteoporotic fractures. However, screening all women is not recommended...
  16. ncbi The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing
    Suzanne M Cadarette
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    Osteoporos Int 15:361-6. 2004
    ..These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion...
  17. ncbi Osteoporosis health belief scale: minor changes were required after telephone administration among women
    Suzanne M Cadarette
    Department of Health Policy, Management and Evaluation, University of Toronto, McMurrich Building, 2nd Floor, 12 Queen s Park Crescent West, Toronto, ON M5S 1A8, Canada
    J Clin Epidemiol 57:154-66. 2004
    ..The purpose of this study was to examine the psychometric properties of the OHBS by telephone administration among older women...
  18. ncbi Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario, Canada
    Suzanne M Cadarette
    Department of Health Policy, University of Toronto, Toronto, Ontario, Canada
    J Rheumatol 32:550-8. 2005
    ..To estimate the prevalence of self-reported osteoporotic fractures and use of bone-sparing agents, and to examine if region of residence is associated with fracture or treatment prevalence...
  19. ncbi Psychometric properties of the "Osteoporosis and You" questionnaire: osteoporosis knowledge deficits among older community-dwelling women
    S M Cadarette
    Osteoporosis Research Program, Women s College Hospital, Toronto, ON, Canada
    Osteoporos Int 18:981-9. 2007
    ..However, significant knowledge deficits were identified regarding osteoporosis "consequences" and "prevention and treatment."..
  20. ncbi The impact of pharmacist interventions on osteoporosis management: a systematic review
    M N Elias
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada
    Osteoporos Int 22:2587-96. 2011
    ..Results from randomized controlled trials suggest that pharmacist interventions may improve bone mineral density testing and calcium intake among patients at high risk for osteoporosis...
  21. ncbi Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial
    S B Jaglal
    Toronto Rehabilitation Institute, Toronto, ON, Canada
    Osteoporos Int 23:87-95. 2012
    ..Compared with controls, intervention patients were five times more likely to receive BMD testing and two times more likely to receive appropriate management...
  22. ncbi Development of an integrated-care delivery model for post-fracture care in Ontario, Canada
    S B Jaglal
    Department of Physical Therapy, University of Toronto, 160 500 University Ave, Toronto, ON, M5G 1V7, Canada
    Osteoporos Int 17:1337-45. 2006
    ....
  23. ncbi Patterns of use of the bone mineral density test in Ontario, 1992-1998
    S B Jaglal
    Department of Physical Therapy, University of Toronto
    CMAJ 163:1139-43. 2000
    ..The purpose of this study was to examine patterns of use of BMD testing in Ontario between 1992 and 1998...
  24. ncbi Correlates of forearm bone mineral density in young Norwegian women: the Nord-Trøndelag Health Study
    Gillian A Hawker
    Division of Rheumatology, Women s College Ambulatory Care Centre, Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
    Am J Epidemiol 156:418-27. 2002
    ..Further studies exploring the relation between lifestyle factors and BMD are warranted to search for ways to maximize attainment of peak BMD...
  25. ncbi How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs
    Susan B Jaglal
    Ontario Ministry of Health and Long Term Care
    Can Fam Physician 49:462-8. 2003
    ..To explore family physicians' experiences and perceptions of osteoporosis and to identify their educational needs in this area...
  26. ncbi Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process
    Susan B Jaglal
    Graduate Department of Rehabilitation Science, University of Toronto, Toronto, ON, Canada
    Osteoporos Int 14:672-6. 2003
    ....
  27. ncbi Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts 02120, USA
    Ann Intern Med 148:637-46. 2008
    ..Little information is available on the comparative effectiveness of osteoporosis pharmacotherapies...
  28. ncbi Biological, social, and environmental correlates of preschool development
    T To
    Population Health Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada
    Child Care Health Dev 27:187-200. 2001
    ..Social and environmental factors appear to play a larger role among older children. Prospective studies are required to determine the effect of change in risk factor profiles on child development...
  29. ncbi High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania
    Jennifer M Polinski
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    Int Q Community Health Educ 29:223-40. 2008
    ..We found several correlates of readiness to undergo BMD screening that may be used to design effective interventions...
  30. ncbi Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, MA 02120, USA
    Am J Epidemiol 166:348-54. 2007
    ..Further work is needed to identify study design and analysis methods that can be used to minimize the healthy user bias in studies of preventive therapies...
  31. ncbi The complex relation between bisphosphonate adherence and fracture reduction
    Amanda R Patrick
    Divisions of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    J Clin Endocrinol Metab 95:3251-9. 2010
    ....
  32. ncbi A cohort study of thiazolidinediones and fractures in older adults with diabetes
    Daniel H Solomon
    Division of Rheumatology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Clin Endocrinol Metab 94:2792-8. 2009
    ..Recent results from several randomized controlled trials find an increased risk of fracture with TZDs compared with other oral antidiabetic agents...
  33. ncbi Osteoporosis treatments and adverse events
    Daniel H Solomon
    Division of Rheumatology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Curr Opin Rheumatol 21:363-8. 2009
    ..Recent case reports cite a range of potential adverse events. We review data regarding atrial fibrillation, bone pain, osteonecrosis of the jaw (ONJ), atypical fractures, and osteosarcoma...